Roberto Mester, MD
- 3Articles
- 9.4KReads
- 1997–2003Active
- 12Collaborators
About
Roberto Mester, MD, has published extensively on the treatment of schizophrenia and schizoaffective disorders, with a focus on pharmacological interventions and their effects on symptoms such as impulsive aggression, suicidality, and neuroleptic-induced movement disorders. His work includes studies comparing antipsychotic medications like clozapine, haloperidol, risperidone, and olanzapine, as well as investigations into the impact of these drugs on bone mineral density in female premenopausal patients. Mester's research, appearing between 1997 and 2003, often addresses clinical challenges related to violence, aggression, and side effects of antipsychotic treatment.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
